Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,042 | 231 | 96.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $133.25 | 1 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $948.61 | 63 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $468.68 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $383.63 | 25 | $0 (2024) |
| Celgene Corporation | $379.55 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $255.17 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $224.32 | 20 | $0 (2024) |
| GENZYME CORPORATION | $178.08 | 9 | $0 (2024) |
| Madrigal Pharmaceuticals | $165.91 | 2 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $152.22 | 3 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $136.49 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,464 | 75 | ABBVIE INC. ($350.77) |
| 2023 | $1,274 | 58 | ABBVIE INC. ($301.29) |
| 2022 | $64.01 | 3 | Janssen Biotech, Inc. ($48.14) |
| 2021 | $32.74 | 2 | AbbVie Inc. ($32.74) |
| 2020 | $196.29 | 12 | AbbVie Inc. ($62.54) |
| 2019 | $552.03 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($129.63) |
| 2018 | $384.59 | 22 | FUJIFILM Medical Systems USA, Inc. ($133.25) |
| 2017 | $207.33 | 17 | AbbVie, Inc. ($65.09) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: INFLIXIMAB | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Organon Llc | HADLIMA (Drug), RENFLEXIS | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $144.48 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 631 | 677 | $372,922 | $73,112 |
| 2022 | 10 | 530 | 588 | $265,562 | $58,574 |
| 2021 | 14 | 677 | 764 | $309,529 | $78,232 |
| 2020 | 14 | 622 | 694 | $291,646 | $58,924 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 95 | 97 | $110,386 | $19,371 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 176 | $44,000 | $15,917 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 120 | 120 | $39,360 | $13,028 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 47 | $16,638 | $6,500 | 39.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 47 | 48 | $26,208 | $4,101 | 15.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 51 | $13,806 | $3,100 | 22.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $14,052 | $2,666 | 19.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $56,289 | $2,297 | 4.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $8,052 | $1,979 | 24.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $25,471 | $1,806 | 7.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,052 | $1,280 | 15.9% |
| 43450 | Dilation of esophagus | Facility | 2023 | 34 | 34 | $10,608 | $1,068 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 183 | $37,252 | $16,141 | 43.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 71 | 71 | $80,798 | $12,912 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 104 | 104 | $32,112 | $11,683 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 44 | $12,720 | $5,775 | 45.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 49 | $23,712 | $3,675 | 15.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 41 | 41 | $46,330 | $3,251 | 7.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $17,864 | $1,835 | 10.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 32 | $6,710 | $1,790 | 26.7% |
| 43450 | Dilation of esophagus | Facility | 2022 | 28 | 28 | $6,228 | $843.10 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,836 | $668.00 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 248 | $47,455 | $22,272 | 46.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 79 | 80 | $91,040 | $15,174 | 16.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 99 | 99 | $30,056 | $11,253 | 37.4% |
About Dr. Ilyas Ikramuddin, D.O
Dr. Ilyas Ikramuddin, D.O is a Gastroenterology healthcare provider based in Beavercreek, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457352940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilyas Ikramuddin, D.O has received a total of $4,175 in payments from pharmaceutical and medical device companies, with $1,464 received in 2024. These payments were reported across 232 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,042).
As a Medicare-enrolled provider, Ikramuddin has provided services to 2,460 Medicare beneficiaries, totaling 2,723 services with total Medicare billing of $268,843. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Beavercreek, OH
- Active Since 08/09/2005
- Last Updated 08/24/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1457352940
Products in Payments
- ZEPOSIA (Drug) $742.82
- RINVOQ (Biological) $293.25
- XIFAXAN (Drug) $235.42
- CREON (Drug) $219.48
- DUPIXENT (Biological) $209.98
- OCALIVA (Drug) $152.22
- REZDIFFRA (Drug) $144.48
- VOQUEZNA (Drug) $136.49
- ESD - Core Endoscopy (Device) $133.25
- STELARA (Biological) $121.60
- REMICADE (Biological) $110.95
- SKYRIZI (Biological) $98.43
- XELJANZ (Drug) $93.11
- Amitiza (Drug) $85.41
- TRULANCE (Drug) $82.21
- Entyvio (Biological) $81.69
- Humira (Biological) $79.25
- VIBERZI (Drug) $76.56
- Mavyret (Drug) $69.92
- Creon (Drug) $52.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Beavercreek
Ben Thomas, D.o, D.O
Gastroenterology — Payments: $14,562
Dr. Michael Gorsky, M.d, M.D
Gastroenterology — Payments: $3,943
Dr. Aaron Knoll, Md, MD
Gastroenterology — Payments: $3,260
Dr. Steven Dellon, M.d, M.D
Gastroenterology — Payments: $2,950
Dr. Azaan Akbar, D.o, D.O
Gastroenterology — Payments: $2,894
Niaz Usman, M.d, M.D
Gastroenterology — Payments: $2,453